Found: 7
Select item for more details and to access through your institution.
The development of sarcoidosis with the use of alemtuzumab – clues to T-cell immune reconstitution.
- Published in:
- 2007
- By:
- Publication type:
- Letter
Lenalidomide can be highly effective in chronic lymphocytic leukaemia despite T-cell depletion and deletion of chromosome 17p.
- Published in:
- European Journal of Haematology, 2011, v. 87, n. 4, p. 372, doi. 10.1111/j.1600-0609.2011.01667.x
- By:
- Publication type:
- Article
The efficacy and safety of venetoclax therapy in elderly patients with relapsed, refractory chronic lymphocytic leukaemia.
- Published in:
- British Journal of Haematology, 2020, v. 188, n. 6, p. 918, doi. 10.1111/bjh.16271
- By:
- Publication type:
- Article
Efficacy of venetoclax monotherapy in patients with relapsed chronic lymphocytic leukaemia in the post‐BCR inhibitor setting: a UK wide analysis.
- Published in:
- British Journal of Haematology, 2019, v. 185, n. 4, p. 656, doi. 10.1111/bjh.15802
- By:
- Publication type:
- Article
Central nervous system plasmablastic lymphoma evolving from polyclonal plasmacytosis.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Results of a multicentre UK-wide compassionate use programme evaluating the efficacy of idelalisib monotherapy in relapsed, refractory follicular lymphoma.
- Published in:
- British Journal of Haematology, 2018, v. 181, n. 4, p. 555, doi. 10.1111/bjh.14665
- By:
- Publication type:
- Article
Results of a multicentre UK-wide retrospective study evaluating the efficacy of brentuximab vedotin in relapsed, refractory classical Hodgkin lymphoma in the transplant naive setting.
- Published in:
- British Journal of Haematology, 2017, v. 179, n. 3, p. 471, doi. 10.1111/bjh.14898
- By:
- Publication type:
- Article